TUMOLO ANNETTE
Known title: Executive Vice PresidentCIK: 0001717996
Associated companies
Transaction History
| BIO | ▲ Buy | Option Exercise | 600 | $96K | 11/12/2021 | View on chart |
| BIO | ▲ Buy | Option Exercise | 2,400 | $518K | 11/12/2021 | View on chart |
| BIO | ▲ Buy | Option Exercise | 1,800 | $587K | 11/12/2021 | View on chart |
| BIO | ▼ Sell | Open Market | 4,800 | $3.6M | 11/12/2021 | View on chart |
| BIO | ▲ Buy | Option Exercise | 613 | $204K | 11/11/2021 | View on chart |
| BIO | ▲ Buy | Option Exercise | 500 | $167K | 11/11/2021 | View on chart |
| BIO | ▲ Buy | Option Exercise | 433 | $227K | 11/11/2021 | View on chart |
| BIO | ▼ Sell | Open Market | 433 | $324K | 11/11/2021 | View on chart |
| BIO | ▼ Sell | Open Market | 613 | $459K | 11/11/2021 | View on chart |
| BIO | ▼ Sell | Open Market | 500 | $375K | 11/11/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.